EUVIMEDEUVIMED entdecken
Crossref

Simultaneous Determination of Amlodipine and Naringin in Rat Plasma by LC–MS: Method Development and Validation

Vishala Rani Baraily iD, Bhupendra Shrestha iD, Sunanda Tuladhar iD, Jithendar Reddy Mandhadi iD

Biomedical Chromatography · 2026-07 · 40 (7)

DOI: 10.1002/bmc.70524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 14.06.2026. Verfasst von Vishala Rani Baraily und 3 weiteren Autor:innen. Beteiligte Einrichtung: Assam down town University, Guwahati, Assam, India. Hauptthemen laut MEDLINE: Flavanones, Amlodipine, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Naringin, a citrus flavanone glycoside, inhibits CYP3A4 and P ‐glycoprotein, making it a clinically relevant modulator of drug bioavailability. Amlodipine, a widely prescribed calcium channel blocker, metabolised by CYP3A4, is susceptible to pharmacokinetic interactions with citrus‐derived flavonoids. A LC–MS bioanalytical method was developed and fully validated for simultaneous quantification of amlodipine and naringin in rat plasma per ICH M10(2022) guidelines. Separation was achieved on a Waters C18 column (250 * 4.6 mm, 3 μm) with gradient elution using 10 mM ammonium acetate (pH 3.0) and acetonitrile. Detection employed positive electrospray ionisation at m / z 409.02,579.2 and 271.1 for amlodipine, naringin and naringenin (internal standard), respectively. Protein precipitation by addition of acetonitrile was employed for sample preparation. Calibration curves were linear over 24.01–2020.6 ng/mL (amlodipine) and 94.01–2012 ng/mL (naringin). Precision (%CV ≤ 15%), accuracy (85%–115%), and stability under all tested conditions met acceptance criteria. The validated method was utilized to analyse the non‐compartmental pharmacokinetics study in Wistar albino rats after oral amlodipine (1 mg/kg), naringin (15 mg/kg), and their combination. Co‐administration led to increased amlodipine C max (~2.2‐fold; p < 0.01), AUC 0–∞ (~2.0‐fold; p < 0.01), and decreased oral clearance. This is the first simultaneous LC–MS approach in conformity with ICH M10 (202) that provides a reliable preclinical citrus flavonoid‐drug interaction tool.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesAmlodipineLiquid Chromatography-Mass SpectrometryAnimalsReproducibility of ResultsRatsLinear ModelsMaleDrug StabilityLimit of Detection

Stichwörter der Autor:innen

LC–MSamlodipinebioanalytical method validationnaringinsimultaneous

Substanzen

FlavanonesnaringinAmlodipine

Autor:innen und Institutionen

  • Assam down town University, Guwahati, Assam, India.
  • Himalayan Pharmacy Institute, East Sikkim, India.
  • Bengal College of Pharmaceutical Sciences and Research, Durgapur, West Bengal, India.

ORCID-Profile: Vishala Rani Baraily, Bhupendra Shrestha, Sunanda Tuladhar, Jithendar Reddy Mandhadi

Zitieren

APA

Baraily, V. R., Shrestha, B., Tuladhar, S., & Mandhadi, J. R. (2026). Simultaneous Determination of Amlodipine and Naringin in Rat Plasma by LC–MS: Method Development and Validation. Biomedical Chromatography, 40(7). https://doi.org/10.1002/bmc.70524

Vancouver

Baraily VR, Shrestha B, Tuladhar S, Mandhadi JR. Simultaneous Determination of Amlodipine and Naringin in Rat Plasma by LC–MS: Method Development and Validation. Biomedical Chromatography. 2026;40(7). doi:10.1002/bmc.70524

BibTeX
@article{Baraily2026,
  author = {Baraily, Vishala Rani and Shrestha, Bhupendra and Tuladhar, Sunanda and Mandhadi, Jithendar Reddy},
  title = {Simultaneous Determination of Amlodipine and Naringin in Rat Plasma by LC–MS: Method Development and Validation},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {7},
  doi = {10.1002/bmc.70524}
}
Kostenlos starten →